Viking Therapeutics Inc. | Ownership
Companies that own Viking Therapeutics Inc.
venBio Select Advisor LLC
4,471,300
7.37%
4,471,300
1.99%
06/30/2018
Tavistock Life Sciences Co. (Investment Management)
3,750,000
6.18%
564,000
3.36%
06/30/2018
BlackRock Fund Advisors
2,721,396
4.49%
2,416,619
0%
06/30/2018
The Vanguard Group, Inc.
2,283,206
3.76%
778,287
0%
06/30/2018
Henderson Global Investors Ltd.
2,060,286
3.4%
2,060,286
0.01%
06/30/2018
ArrowMark Colorado Holdings LLC
1,723,982
2.84%
95,231
0.2%
06/30/2018
Opaleye Management, Inc.
1,200,000
1.98%
99,200
3.96%
06/30/2018
Sphera Funds Management Ltd.
782,424
1.29%
-809,992
1.48%
06/30/2018
Acuta Capital Partners LLC
750,000
1.24%
750,000
1.71%
06/30/2018
Millennium Management LLC
740,604
1.22%
-658,766
0.01%
06/30/2018
| Address |
12340 El Camino Real
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.vikingtherapeutics.com |
| Updated |
07/08/2019 |
| Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Its clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. |
